Leptin: A proliferative factor for breast cancer?

• Published in: Biochemical and biophysical research communications Vol. 334; no. 3; pp. 737 - 741
• Main Authors: Caldefie-Chézet, F., Damez, M., de Latour, M., Konska, G., Mishellani, F., Fusillier, C., Guerry, M., Penault-Llorca, F., Guillot, J., Vasson, M.-P.
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01-09-2005
• Subjects: Breast; Breast cancer; Diagnostic; Ductal carcinoma; Leptin; Ob protein; Proliferative factor; Pronostic; Tumors; Ob protein; Ductal carcinoma; Leptin; Proliferative factor; Breast; Diagnostic; Breast cancer; Pronostic; Tumors
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1016/j.bbrc.2005.06.077

Mammary adipose tissue is an important source of paracrine mitogens and anti-mitogens, including insulin-like growth factor, transforming growth factors, and cytokines (especially, TNFα and IL-1β). Nevertheless, it is also an important source of the adipocytokine, leptin. Recently, leptin was reported to stimulate the proliferation of various cell types (pancreatic β cells, prostate, colorectal, lung, etc.) as a new growth factor. It was also shown to stimulate the proliferation of breast cancer cell lines. In this study, we conducted an immunohistochemical analysis of leptin expression in normal tissue and benign and malignant ductal breast cell, representing the different states of the invasion process. We determined for the first time that leptin is expressed both by ductal breast tumors and by benign lesions as atypical hyperplasia. This suggests that leptin may be taken up or synthesized by all modified ductal breast cells, and may prove a proliferative factor. Moreover, leptin is unexpressed by normal tissue in the healthy breast but is exhibited by the normal tissue in near vicinity of the malignant ductal breast lesions. We also postulated that leptin may be a prognostic or diagnostic factor for ductal breast cancer. These putative hypotheses require further study.